Global Cardiac Rhythm Management Devices Market, By Product (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)), Application (Bradycardia, Tachycardia, Heart Failure, Others), End User (Hospital, Home Care Settings, Ambulatory Care Settings) - Industry Trends and Forecast to 2030.
Cardiac Rhythm Management Devices Market Analysis and Size
Patients with heart rate and rhythm issues can maintain a normal cardiac rhythm with the aid of cardiac rhythm management devices. Major cardiac disorders such as heart failure, atrial fibrillation, atrial flutter, recent heart attack warning symptoms, coronary ischemia, inadequate oxygen transport to cardiac muscles, pharmacological side effects, and genetic errors, among others, require the use of these devices. Increases in cardiac ailments, technological advancements, patient awareness, and the amount of unmet medical needs in developing and undeveloped nations are some of the factors propelling the market. The global cardiac rhythm management devices market is expected to witness significant growth during the forecast period of 2023 to 2030.
Data Bridge Market Research analyses that the global cardiac rhythm management devices market which was USD 19.05 billion in 2022, is expected to reach USD 28.69 billion by 2030, and is expected to undergo a CAGR of 5.25% during the forecast period of 2023 to 2030. “Hospitals” dominates the product type segment of the global cardiac rhythm management devices market due to presence of highly skilled physicians. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cardiac Rhythm Management Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)), Application (Bradycardia, Tachycardia, Heart Failure, Others), End User (Hospital, Home Care Settings, Ambulatory Care Settings)
|
|
Countries Covered
|
U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Physio-Control, Inc. (U.S.), Schiller Americas, Inc. (Switzerland), Medtronic (Ireland), Abbott (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), General electric (U.S.), Asahi Kasei Corporation (Japan), MicroPort Scientific Corporation (China), NIHON KOHDEN CORPORATION (Japan), BPL Medical Technologies (India), Pacetronix (U.S.), Osypka Medical (Germany), AliveCor, Inc (U.S.), Stryker (U.S.), Koninklijke Philips N.V. (Netherlands), and LivaNova Plc (U.K.)
|
|
Market Opportunities
|
|
Market Definition
Cardiac management devices are medical instruments designed to monitor, regulate, and support the functioning of the heart. Pacemakers, for instance, are implanted devices that emit electrical signals to control irregular heartbeats and ensure a steady rhythm. Implantable cardioverter-defibrillators (ICDs) are another instance, capable of detecting and correcting dangerous heart rhythms by delivering controlled electric shocks. Cardiac resynchronization therapy (CRT) devices coordinate the contractions of the heart's chambers to improve pumping efficiency. These devices are crucial in treating conditions like arrhythmias and heart failure, significantly impacting the quality of life for patients with cardiovascular disorders.
Global Cardiac Rhythm Management Devices Market Dynamics
Drivers
- Rising Prevalence of Cardiovascular Diseases
The escalating global burden of cardiovascular diseases, including heart failure, coronary artery disease, and arrhythmias, is a primary driver for the global cardiac management devices market. Lifestyle factors such as sedentary living, unhealthy diets, and increased stress contribute to the rise in cardiovascular conditions. As these diseases become more prevalent, the demand for advanced cardiac devices for monitoring and treatment purposes intensifies, fostering market growth. In addition, the aging population worldwide further amplifies the need for effective cardiac management solutions.
- Increased Awareness of Cardiovascular Health
A heightened awareness of cardiovascular health, driven by healthcare campaigns, educational initiatives, and media coverage, plays a pivotal role in the growth of the global cardiac management devices market. Individuals are becoming more conscious of the importance of regular heart check-ups and early intervention. This increased awareness leads to a proactive approach to heart health, prompting both healthcare professionals and patients to adopt advanced cardiac management technologies. As a result, there is a positive impact on early diagnosis, treatment, and overall market expansion.
Opportunities
- Innovation and Research Opportunities
As the market expands, there is a significant opportunity for increased investment in research and development. Innovations in technologies, such as advanced sensing capabilities, miniaturization, and improved battery life for devices, can lead to the development of more efficient and patient friendly cardiac management solutions.
- Digitalization and Integration of Health Data
The growth of the market creates opportunities for the integration of digital health solutions. Remote monitoring, telemedicine, and data analytics can enhance the efficiency of cardiac management, providing continuous monitoring and personalized care. This shift towards digital health opens avenues for partnerships between device manufacturers and technology companies.
Restraints/Challenges
- Cost Constraints with Devices Used in market
The high cost associated with advanced cardiac management devices, including the initial implantation procedure and ongoing maintenance, poses a significant challenge. Affordability concerns may limit access to these life-saving technologies, particularly in regions with constrained healthcare budgets. Striking a balance between technological innovation and cost-effectiveness is crucial to ensure widespread adoption and equitable access to cardiac care.
- Limited Accessibility in Developing Regions
Access to advanced cardiac management devices faces challenges in developing regions with inadequate healthcare infrastructure. The lack of resources, trained medical professionals, and facilities capable of performing specialized procedures hinders accessibility. Addressing this challenge requires targeted investments in healthcare infrastructure, education, and strategic partnerships to extend the reach of cardiac management technologies to underserved populations, fostering global health equity.
This global cardiac management devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cardiac management devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In October 2020, Abbott has launched its new implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices for abnormal heart rhythms and heart failure in the Indian market. The device offer new opportunities for patient engagement and remote monitoring through smartphone connectivity
Global Cardiac Rhythm Management Devices Market Scope
The global cardiac management devices market is segmented on the basis of product, application, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Pacemakers
- Defibrillators
- Cardiac Resynchronization Therapy (CRT)
Application
- Bradycardia
- Tachycardia
- Heart Failure
- Others
End User
- Hospital
- Home Care Settings
- Ambulatory Care Settings
Global Cardiac Rhythm Management Devices Market Regional Analysis/Insights
The global cardiac management devices market is analysed and market size insights and trends are provided by product, application, and end user as referenced above.
The countries covered in the global cardiac management devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the global cardiac management devices market owing to various factors such as well-established healthcare infrastructure, increasing elderly population, rapid adoption of technologically advanced products etc.
Asia-Pacific is expected to grow at the highest growth rate in the global cardiac management devices market during the forecast period of 2023 to 2030, due to the rising demand of advanced technology and improved healthcare infrastructure.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global cardiac management devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global cardiac management devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global cardiac management devices market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Cardiac Rhythm Management Devices Market Share Analysis
The global cardiac management devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global cardiac management devices market.
Some of the major players operating in the global cardiac management devices market are:
- Physio-Control, Inc. (U.S.)
- Schiller Americas, Inc. (Switzerland)
- Medtronic (Ireland)
- Abbott (U.S.)
- Boston Scientific Corporation (U.S.)
- BIOTRONIK SE & Co. KG (Germany)
- General electric (U.S.)
- Asahi Kasei Corporation (Japan)
- MicroPort Scientific Corporation (China)
- NIHON KOHDEN CORPORATION (Japan)
- BPL Medical Technologies (India)
- Pacetronix (U.S.)
- Osypka Medical (Germany)
- AliveCor, Inc (U.S.)
- Stryker (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- LivaNova Plc (U.K.)
SKU-